EPITHELIAL-CELL SPECIFIC PROPERTIES AND GENETIC COMPLEMENTATION IN A DELTA-F508 CYSTIC-FIBROSIS NASAL POLYP CELL-LINE

被引:0
|
作者
KUNZELMANN, K
LEI, DC
ENG, K
ESCOBAR, LC
KOSLOWSKY, T
GRUENERT, DC
机构
[1] UNIV CALIF SAN FRANCISCO,CARDIOVASC RES INST,SAN FRANCISCO,CA 94143
[2] UNIV CALIF SAN FRANCISCO,CTR GENE THERAPY CORE,SAN FRANCISCO,CA 94143
[3] UNIV CALIF SAN FRANCISCO,DEPT LAB MED,SAN FRANCISCO,CA 94143
[4] UNIV FREIBURG,INST PHYSIOL,W-7800 FREIBURG,GERMANY
关键词
CF AIRWAY EPITHELIAL CELLS; DELTA-F508; CFTR; SECRETORY CELL; TRANSFORMATION; ION TRANSPORT; GENE THERAPY;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Analysis of vectorial ion transport and protein trafficking in transformed cystic fibrosis (CF) epithelial cells has been limited because the cells tend to lose their tight junctions with multiple subcultures. To elucidate ion transport and protein trafficking in CF epithelial cells, a polar cell line with apical and basolateral compartments will facilitate analysis of the efficacy of different gene therapy strategies in a ''tight epithelium'' in vitro. This study investigates the genotypic and phenotypic properties of a CF nasal polyp epithelial, Delta F508 homozygote, cell line that has tight junctions pre-crisis. The cells (Sigma CFNPE14o-) were transformed with an origin-of-replication defective SV40 plasmid. They develop transepithelial resistance in Ussing chambers and are defective in cAMP-dependent Cl- transport as measured by efflux of radioactive Cl-, short circuit current (I-se), or whole-cell patch clamp. Stimulation of the cells by bradykinin, histamine, or ATP seems to activate both K+- and Ca+2-dependent Cl- transport. Measurement of Cl-36(-) efflux following stimulation with A23187 and ionomycin indicate a Ca+2-dependent Cl- transport. Volume regulatory capacity of the cells is indicated by cell swelling conductance. Expression of the CF transmembrane conductance regulator mRNA was indicated by RT-PCR amplification. When cells are grown at 26 degrees C for 48 h there is no indication of cAMP-dependent Cl- as has been previously indicated in heterologous expression systems. Antibodies specific for secretory cell antigens indicate the presence of antigens found in goblet, serous, and mucous cells; in goblet and serous cells; or in goblet and mucous cells; but not antigens found exclusively in mucous or serous cells. Gene complementation studies with an episomal vector containing wild-type CF transmembrane conductance regulator cDNA showed correction of the cAMP-dependent Cl- transport defect. This cell line contributes unique phenotypic features to the store of transformed CF epithelial cells already available.
引用
收藏
页码:617 / 624
页数:8
相关论文
共 50 条
  • [21] CHRONIC BRONCHIAL SECRETION IN DELTA-F508 HETEROZYGOTE FOR CYSTIC-FIBROSIS
    SMITH, DL
    STABLEFORTH, DE
    CUSHLEY, M
    LANCET, 1991, 337 (8735): : 234 - 234
  • [22] FREQUENCY OF DELTA-F508 IN A MEXICAN SAMPLE OF CYSTIC-FIBROSIS PATIENTS
    OROZCO, L
    SALCEDO, M
    LEZANA, JL
    CHAVEZ, M
    VALDEZ, H
    MORENO, M
    CARNEVALE, A
    JOURNAL OF MEDICAL GENETICS, 1993, 30 (06) : 501 - 502
  • [23] THE DELTA-F508 MUTATION IN MILD ADULT FORMS OF CYSTIC-FIBROSIS (CF)
    SIMONBOUY, B
    MORNET, E
    TAILLANDIER, A
    SERRE, JL
    BOUE, J
    BOUE, A
    CLINICAL GENETICS, 1991, 39 (04) : 304 - 305
  • [24] PREIMPLANTATION DIAGNOSIS OF DELTA-F508 MUTATION OF CYSTIC-FIBROSIS IN TRANSGENIC MICE
    JI, YZ
    NICOLAS, JC
    MARECHAL, V
    DESIRE, N
    PAVIRANI, A
    MILLIEZ, J
    PRESSE MEDICALE, 1995, 24 (26): : 1193 - 1197
  • [25] CLINICAL CHARACTERIZATION OF CYSTIC-FIBROSIS PATIENTS CARRYING THE DELTA-F508 MUTATION
    KEREM, E
    KEREM, BS
    COREY, M
    ROMMENS, J
    LEVISON, H
    TSUI, LC
    DURIE, P
    PEDIATRIC RESEARCH, 1990, 27 (04) : A358 - A358
  • [26] THE ORIGIN OF THE MAJOR CYSTIC-FIBROSIS MUTATION (DELTA-F508) IN EUROPEAN POPULATIONS
    MORRAL, N
    BERTRANPETIT, J
    ESTIVILL, X
    NUNES, V
    CASALS, T
    GIMENEZ, J
    REIS, A
    VARONMATEEVA, R
    MACEK, M
    KALAYDJIEVA, L
    ANGELICHEVA, D
    DANCHEVA, R
    ROMEO, G
    RUSSO, MP
    GARNERONE, S
    RESTAGNO, G
    FERRARI, M
    MAGNANI, C
    CLAUSTRES, M
    DESGEORGES, M
    SCHWARTZ, M
    SCHWARZ, M
    DALLAPICCOLA, B
    NOVELLI, G
    FEREC, C
    DEARCE, M
    NEMETI, M
    KERE, T
    ANVRET, M
    DAHL, N
    KADASI, L
    NATURE GENETICS, 1994, 7 (02) : 169 - 175
  • [27] PREVALENCE OF THE DELTA-F508 DELETION OF THE CYSTIC-FIBROSIS GENE IN BELGIAN PATIENTS
    COCHAUX, P
    VANGEFFEL, R
    BARAN, D
    PONCIN, J
    VASSART, G
    HUMAN GENETICS, 1990, 85 (04) : 400 - 400
  • [28] A POOLING STRATEGY FOR HETEROZYGOTE SCREENING OF THE DELTA-F508 CYSTIC-FIBROSIS MUTATION
    GILLE, C
    GRADE, K
    COUTELLE, C
    HUMAN GENETICS, 1991, 86 (03) : 289 - 291
  • [29] CYSTIC-FIBROSIS MUTATION DELTA-F508 IN FINLAND - OTHER MUTATIONS PREDOMINATE
    KERE, J
    SAVILAHTI, E
    NORIO, R
    ESTIVILL, X
    DELACHAPELLE, A
    HUMAN GENETICS, 1990, 85 (04) : 413 - 415
  • [30] SEVERITY OF CYSTIC-FIBROSIS IN PATIENTS HOMOZYGOUS AND HETEROZYGOUS FOR DELTA-F508 MUTATION
    JOHANSEN, HK
    NIR, M
    HOIBY, N
    KOCH, C
    SCHWARTZ, M
    LANCET, 1991, 337 (8742): : 631 - 634